首页 正文

[Vemurafenib in refractory langerhans histiocytosis]

{{output}}
Langerhans Cell Histiocytosis (LCH) is a rare disease involving the occurrence of disturbances in the mitogene-activated kinases pathway (MAPK). At present, it is known that the appearance of such disorders is usually connected with a more aggressive form of t... ...